Funding Support and Author Disclosures Dr Doshi has received a grant from Boston Scientific. Dr Dukkipati has received a grant from Biosense Webster; and holds equity in Farapulse and Manual Surgical Sciences. Dr Neuzil has received grants from Biosense Webster and Boston Scientific. Dr Reddy is a consultant to Abbott, Ablacon, Acutus Medical, Affera, Apama Medical, APN Health, Aquaheart, Atacor, AtiAN, Autonomix, Axon Therapies, Backbeat, BioSig, Biosense Webster, BioTel Heart, Biotronik, Boston Scientific, Cardiac Implants, CardiaCare, Cardiofocus, Cardionomic, CardioNXT/AFTx, Circa Scientific, CoreMap, CoRISMA, Corvia Medical, Dinova-Hangzhou Nuomao Medtech, East End Medical, EBR, EPD, Epix Therapeutics, EpiEP, Eximo, Farapulse, Fire1, Gore & Associates, HRT, Impulse Dynamics, Intershunt, Javelin, Kardium, Keystone Heart, LuxCath, Medlumics, Medtronic, Middlepeak, Neutrace, Nuvera, Philips, Pulse Biosciences, Restore Medical, Sirona Medical, and Valcare; and holds equity in Ablacon, Acutus Medical, Affera, Apama Medical, APN Health, Aquaheart, Atacor, Autonomix, Backbeat, BioSig, Cardiac Implants, CardiaCare, Circa Scientific, CoRISMA, Corvia Medical, Dinova-Hangzhou Nuomao Medtech, East End Medical), EPD, Epix Therapeutics, EpiEP, Eximo, Farapulse, Fire1, HRT, Intershunt, Javelin, Kardium, Keystone Heart, LuxCath, Manual Surgical Sciences, Medlumics, Middlepeak, Neutrace, Newpace, Nuvera, Restore Medical, Sirona Medical, Surecor, Valcare, and Vizaramed (Equity). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.